A Study to Evaluate the Clinical Efficacy of JNJ-42756493, A Pan-Fibro
- This topic has 0 replies, 1 voice, and was last updated 8 years, 4 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
A Study to Evaluate the Clinical Efficacy of JNJ-42756493, A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine KinaseInhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Gastric Cancer, Esophageal Cancer Or Cholangiocarcinoma
Not yet open although start date is March this year.
https://clinicaltrials.gov/ct2/show/NCT02699606
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.